Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby A Eyre

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Leukemia & Lymphoma|March 23, 2025
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaNitin Jain, Toby A Eyre, Katherine B Winfree, et al.
British Journal of Haematology|October 4, 2021
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice PaperToby A Eyre, John C Riches, Piers E M Patten, et al.
Leukemia Research|October 9, 2025
Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemiaLin Wang, Murat Kurt, Tim Disher, et al.
Haematologica|November 30, 2023
Pirtobrutinib <i>versus</i> venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparisonOthman Al-Sawaf, Min-Hua Jen, Lisa M Hess, et al.
British Journal of Haematology|June 25, 2020
The investigation and management of follicular lymphomaChristopher McNamara, Silvia Montoto, Toby A Eyre, et al.
British Journal of Haematology|February 4, 2020
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapyRory McCulloch, Carlo Visco, Toby A Eyre, et al.
European Journal of Haematology|April 9, 2020
DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre studyFaouzi Djebbari, Kanchana De Abrew, Beena Salhan, et al.
Haematologica|October 15, 2020
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of careFaouzi Djebbari, Fotios Panitsas, Toby A Eyre, et al.
British Journal of Haematology|October 26, 2023
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology GuidelineToby A Eyre, Mark J Bishton, Rory McCulloch, et al.
British Journal of Haematology|November 13, 2023
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology GuidelineRenata Walewska, Toby A Eyre, Sally Barrington, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Leukemia & Lymphoma|March 23, 2025
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaNitin Jain, Toby A Eyre, Katherine B Winfree, et al.
British Journal of Haematology|October 4, 2021
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice PaperToby A Eyre, John C Riches, Piers E M Patten, et al.
Leukemia Research|October 9, 2025
Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemiaLin Wang, Murat Kurt, Tim Disher, et al.
Haematologica|November 30, 2023
Pirtobrutinib <i>versus</i> venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparisonOthman Al-Sawaf, Min-Hua Jen, Lisa M Hess, et al.
British Journal of Haematology|June 25, 2020
The investigation and management of follicular lymphomaChristopher McNamara, Silvia Montoto, Toby A Eyre, et al.
British Journal of Haematology|February 4, 2020
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapyRory McCulloch, Carlo Visco, Toby A Eyre, et al.
European Journal of Haematology|April 9, 2020
DPACE-based chemotherapy in the era of myeloma novel agents: A UK multicentre studyFaouzi Djebbari, Kanchana De Abrew, Beena Salhan, et al.
Haematologica|October 15, 2020
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of careFaouzi Djebbari, Fotios Panitsas, Toby A Eyre, et al.
British Journal of Haematology|October 26, 2023
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology GuidelineToby A Eyre, Mark J Bishton, Rory McCulloch, et al.
British Journal of Haematology|November 13, 2023
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology GuidelineRenata Walewska, Toby A Eyre, Sally Barrington, et al.
Pageof 17